The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3262716)

Published in J Diabetes Sci Technol on November 01, 2011

Authors

Ronald L Brazg1, Timothy S Bailey, Satish Garg, Bruce A Buckingham, Robert H Slover, David C Klonoff, Xuan Nguyen, John Shin, John B Welsh, Scott W Lee

Author Affiliations

1: Rainier Clinical Research Institute, Renton, Washington, USA.

Articles by these authors

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med (2010) 8.69

Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med (2013) 6.64

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet (2012) 4.03

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther (2008) 3.82

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85

Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care (2011) 2.83

Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83

Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics (2004) 2.65

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes (2003) 2.51

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther (2012) 2.46

A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes. Diabetes Care (2006) 2.40

Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell. Diabetes Care (2007) 2.30

Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol (2011) 2.28

Characterization of Arabidopsis ABCG11/WBC11, an ATP binding cassette (ABC) transporter that is required for cuticular lipid secretion. Plant J (2007) 2.19

Randomized trial of infusion set function: steel versus teflon. Diabetes Technol Ther (2013) 2.15

The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther (2008) 2.00

The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95

Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol (2002) 1.94

Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sci Technol (2009) 1.93

Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther (2006) 1.89

The missing element of telemedicine for diabetes: decision support software. J Diabetes Sci Technol (2009) 1.83

Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther (2005) 1.75

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials. Clin Ther (2007) 1.73

Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther (2005) 1.70

Time synching or time sinking? Diabetes Technol Ther (2005) 1.70

Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care (2010) 1.66

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care (2005) 1.59

Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care (2005) 1.59

Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes (2007) 1.56

The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges. Diabetes Care (2004) 1.55

Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther (2015) 1.54

Using telemedicine to improve outcomes in diabetes--an emerging technology. J Diabetes Sci Technol (2009) 1.52

Blood glucose meter market: this world is undergoing drastic changes. J Diabetes Sci Technol (2013) 1.51

Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol (2010) 1.48

Self-efficacy impacts self-care and HbA1c in young adults with Type I diabetes. Psychosom Med (2002) 1.45

Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care (2003) 1.43

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care (2005) 1.43

Technical aspects of the Parkes error grid. J Diabetes Sci Technol (2013) 1.41

Second insulin pump safety meeting: summary report. J Diabetes Sci Technol (2010) 1.40

Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. J Diabetes Sci Technol (2012) 1.38

Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther (2014) 1.36

Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms. Diabetes Technol Ther (2011) 1.34

A review of the security of insulin pump infusion systems. J Diabetes Sci Technol (2011) 1.34

Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes (2011) 1.32

Regulatory controversies surround blood glucose monitoring devices. J Diabetes Sci Technol (2010) 1.32

In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther (2009) 1.24

Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther (2010) 1.22

Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin (2010) 1.20

In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol (2009) 1.19

Vitamin D deficiency in the San Francisco Bay Area. J Pediatr Endocrinol Metab (2006) 1.19

Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care (2011) 1.17

Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care (2014) 1.17

New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when this practice is not applied properly. J Diabetes Sci Technol (2008) 1.15

The need for clinical accuracy guidelines for blood glucose monitors. J Diabetes Sci Technol (2012) 1.14

The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care (2011) 1.14

A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator. J Diabetes Sci Technol (2009) 1.12

A closed-loop artificial pancreas based on risk management. J Diabetes Sci Technol (2011) 1.12

Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? Diabetes Care (2003) 1.11

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT. Endocr Pract (2016) 1.09

The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther (2014) 1.08

Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study. Am J Crit Care (2005) 1.08

Ophthalmologic findings in the Cornelia de Lange Syndrome. J AAPOS (2005) 1.08

The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age. Diabetes Technol Ther (2007) 1.07

Personalized medicine for diabetes. J Diabetes Sci Technol (2008) 1.05

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care (2011) 1.04

Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting. Endocr Pract (2011) 1.04

White matter structural differences in young children with type 1 diabetes: a diffusion tensor imaging study. Diabetes Care (2012) 1.03

Use of the Cygnus GlucoWatch biographer at a diabetes camp. Pediatrics (2004) 1.00

SMBG out of control: the need for educating patients about control solution. Diabetes Educ (2013) 0.99

Designing an artificial pancreas system to be compatible with other medical devices. J Diabetes Sci Technol (2008) 0.99

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther (2014) 0.99

A new test strip technology platform for self-monitoring of blood glucose. J Diabetes Sci Technol (2013) 0.98

The current status of bolus calculator decision-support software. J Diabetes Sci Technol (2012) 0.97

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol (2013) 0.97

ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. J Diabetes Sci Technol (2013) 0.95

Outcome measures for outpatient hypoglycemia prevention studies. J Diabetes Sci Technol (2011) 0.95

Probabilistic evolving meal detection and estimation of meal total glucose appearance. J Diabetes Sci Technol (2009) 0.94

Technology to treat hyperglycemia in trauma. J Diabetes Sci Technol (2007) 0.94

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes. Diabetes Technol Ther (2014) 0.93

Gianotti-Crosti syndrome in a postpartum adult. Int J Dermatol (2014) 0.93

Labor characteristics and program costs of a successful diabetes disease management program. Am J Manag Care (2006) 0.93

Practical considerations in the use of real-time continuous glucose monitoring alerts. J Diabetes Sci Technol (2010) 0.92

Subcutaneous continuous glucose monitoring in severe burn patients. Crit Care Med (2007) 0.92

The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis. Diabetes Technol Ther (2013) 0.92

Quality Control of Insulins and Biosimilar Insulins: What Do We Know? J Diabetes Sci Technol (2016) 0.91

Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study. Diabetes Technol Ther (2014) 0.90